Journal of Cancer Research and Experimental Oncology
Subscribe to JCREO
Full Name*
Email Address*

Article Number - AD8630160299


Vol.8(4), pp. 41-46 , September 2016
DOI: 10.5897/JCREO2016.0129
ISSN: 2141-2243



Full Length Research Paper

Prevalence of unilateral arm lymphedema among breast cancer patients one year after completing treatment at Cancer Diseases Hospital in Lusaka



Victoria Mwiinga-Kalusopa
  • Victoria Mwiinga-Kalusopa
  • Department of Nursing Sciences, School of Medicine, University of Zambia, Zambia.
  • Google Scholar
Catherine Ngoma
  • Catherine Ngoma
  • Cancer Diseases Hospital, Lusaka, Zambia, Zambia.
  • Google Scholar







 Received: 21 April 2016  Accepted: 09 August 2016  Published: 30 September 2016

Copyright © 2016 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Lymphedema of the arm and/or hand is a long-term complication of breast cancer treatment.  Accurate estimates of the incidence and prevalence of lymphedema are lacking, as are the effects of this condition on overall quality of life. The objective of this study was to determine the prevalence of unilateral arm lymphedema among breast cancer patients one year after completion of treatment at Cancer Diseases Hospital. The prevalence of unilateral arm lymphedema controlling for cancer stages and treatment types were determined using a cross sectional study. Arm circumference of all breast cancer clients was measured to determine the prevalence of lymphedema. Prevalence of arm lymphedema (95% CI) was mild 60%, moderate was 28% and severe lymphedema was at 12%, respectively with stage I breast cancer patients, only presented with mild form of lymphedema. The study showed that lymphedema after breast cancer is common but mostly mild; increasing the awareness of health professional regarding early diagnosis can help minimize the morbidity of this disease post-surgery and radiation treatments among breast cancer patients.

 

Key words: Lymphedema, breast cancer, patients, arm lymphedema.

Abbreviation:

CDH, Cancer Disease Hospital; HRQoL, health related quality of life; NCI, National Cancer Institution; MEPI, Medical Education Partnership Initiative; SACORE, Southern Africa Consortium for Research Excellence Zambia; UNZA-SoM, University of Zambia School of Medicine; DNS, Department of Nursing Sciences; MSc, Master of Science; MOH, Ministry of Health.


Bar ADV, Dutta PR, Solin LJ, Hwang WT, Tan KS, Both S, Cheville A, Harris EE (2012). Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer. Breast J. 18(3):219-225.
Crossref

 

Cancer Diseases Hospital (2012). Action plan.

 
 

Clark B, Sitzia J, Harlow W (2005). Incidence and risk of arm edema following treatment for breast cancer: a three-year follow-up study. QJM 98(5):343-348.
Crossref

 
 

Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, Raina V (2004). Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J. Cancer 41:8-12.

 
 

Disipio T, Rye S, Newman B, Hayes S (2013). Incidence of unilateral arm lymphedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 14(6):500-505.
Crossref

 
 

Edwards TL (2000). Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Australian New Zealand J. Surg. 70(6):412-418.
Crossref

 
 

Fu MR, Rosedale M (2009). Breast cancer survivors' experiences of lymphedema-related symptoms. J. Pain Symptom Manag. 38:849-859.
Crossref

 
 

Haghighat S, Akbari A, Ansari M, Homaei SF, Najafi M, Ebrahimi M, Yunesian M Mirzaei HR Akbari ME (2013). Risk Factors of Lymph Edema in Breast Cancer Patients. Int. J. Breast Cancer 2013.

 
 

Hayes SC, Johansson KSL, Prosnitz RG, Armer JM, Gabram S, Schmitz KH (2012). Upper body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer 118(S8):2237-2249.
Crossref

 
 

Herd-Smith A. Russo A, Muraca MG, Del Turco MR, Cardona G (2001). "Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 92(7):1783-1787.
Crossref

 
 

Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R (2010). A quality of life measure for limb lymphedema (LYMQOL). J. Lymphedema 5(1):26-37.

 
 

Lawenda BD, Mondry TE, Johnstone PAS (2009). Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment. Cancer J. Clin. 59(1):8.
Crossref

 
 

Maree JE (2011). Yes, breast cancer related lymphoedema can be managed. Health SA Gesondheid 16(1):1-7.
Crossref

 
 

National Cancer Institute (2015). Lymphedema (PDQ®)–Health Professional Version. U.S. Department of Health and Human Services/ National Institutes of Health/National Cancer Institute, USA.gov

 
 

Norman SA, Localio AR, Potashnik SL, Torpey HAS, Kallan MJ, Weber AL, Miller LT, DeMichele A, Solin LJ (2009). Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J. Clin. Oncol. 27(3):390-397.
Crossref

 
 

Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V (2012). Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 21:361-365.
Crossref

 
 

Park JH, Lee WH, Chung HS (2008). Incidence and risk factors of breast cancer lymphedema. J. Clin. Nurs. 17(11):1450-1459.
Crossref

 
 

Paskett ED, Naughton MJ, McCoy TP (2007). The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol. Biomark. Prev. 16:775-782.
Crossref

 
 

Petrek JA, Heelan MC (1998). Incidence of breast carcinoma-related lymphedema. Cancer J. 83:1776-1781.
Crossref

 
 

Pyszel A (2006). Disability, Psychological distress and Quality of Life in breast cancer Survivors with Lymphedema. Lymphology 39:185-192.

 
 

Schunemann H, Willich N (1997). Lymphedema after breast carcinoma. A study of 5868 cases. Dtsch Med. Wochenschr 122(17):536-541.

 
 

UCLA Statistical Consulting Group. Statistical Computing Seminars. 

 
 

Ugur S, Cumhur A, Muhittin Y, Ayhan M, Gulbin A A, Kemal D, and Vahit O (2013). Risk Factors of Breast Cancer-Related Lymphedema. Lymphatic Research and Biology. Lymphat. Res. Biol. 11(2):72-75.
Crossref

 

 


APA Mwiinga-Kalusopa, V., & Ngoma, C. (2016). Prevalence of unilateral arm lymphedema among breast cancer patients one year after completing treatment at Cancer Diseases Hospital in Lusaka. Journal of Cancer Research and Experimental Oncology, 8(4), 41-46.
Chicago Victoria Mwiinga-Kalusopa, Catherine Ngoma. "Prevalence of unilateral arm lymphedema among breast cancer patients one year after completing treatment at Cancer Diseases Hospital in Lusaka." Journal of Cancer Research and Experimental Oncology 8, no. 4 (2016): 41-46.
MLA Victoria Mwiinga-Kalusopa, Catherine Ngoma. "Prevalence of unilateral arm lymphedema among breast cancer patients one year after completing treatment at Cancer Diseases Hospital in Lusaka." Journal of Cancer Research and Experimental Oncology 8.4 (2016): 41-46.
   
DOI 10.5897/JCREO2016.0129
URL http://academicjournals.org/journal/JCREO/article-abstract/AD8630160299

Subscription Form